-
2
-
-
84863974565
-
Current insights into the pathophysiology of Alzheimer's disease: Selecting targets for early therapeutic intervention
-
Hampel H (2012) Current insights into the pathophysiology of Alzheimer's disease: selecting targets for early therapeutic intervention. Int Psychogeriatr 24(Suppl 1), S10-S17.
-
(2012)
Int Psychogeriatr
, vol.24
, pp. S10-S17
-
-
Hampel, H.1
-
3
-
-
79956142378
-
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 263-269
-
-
McKhann, G.M.1
Knopman, D.S.2
Chertkow, H.3
Hyman, B.T.4
Jack, C.R.5
Kawas, C.H.6
Klunk, W.E.7
Koroshetz, W.J.8
Manly, J.J.9
Mayeux, R.10
Mohs, R.C.11
Morris, J.C.12
Rossor, M.N.13
Scheltens, P.14
Carrillo, M.C.15
Thies, B.16
Weintraub, S.17
Phelps, C.H.18
-
4
-
-
0001644020
-
The human plasma proteome: History, character, and diagnostic prospects
-
Anderson NL, Anderson NG (2002) The human plasma proteome: History, character, and diagnostic prospects. Mol Cell Proteomics 1, 845-867.
-
(2002)
Mol Cell Proteomics
, vol.1
, pp. 845-867
-
-
Anderson, N.L.1
Anderson, N.G.2
-
5
-
-
33750596715
-
Proteome-based plasma biomarkers for Alzheimer's disease
-
Hye A, Lynham S, Thambisetty M, Causevic M, Campbell J, Byers HL, Hooper C, Rijsdijk F, Tabrizi SJ, Banner S, Shaw CE, Foy C, Poppe M, Archer N, Hamilton G, Powell J, Brown RG, Sham P, Ward M, Lovestone S (2006) Proteome-based plasma biomarkers for Alzheimer's disease. Brain 129, 3042-3050.
-
(2006)
Brain
, vol.129
, pp. 3042-3050
-
-
Hye, A.1
Lynham, S.2
Thambisetty, M.3
Causevic, M.4
Campbell, J.5
Byers, H.L.6
Hooper, C.7
Rijsdijk, F.8
Tabrizi, S.J.9
Banner, S.10
Shaw, C.E.11
Foy, C.12
Poppe, M.13
Archer, N.14
Hamilton, G.15
Powell, J.16
Brown, R.G.17
Sham, P.18
Ward, M.19
Lovestone, S.20
more..
-
6
-
-
84866246671
-
Microglia, Alzheimer's disease, and complement
-
Crehan H, Hardy J, Pocock J (2012) Microglia, Alzheimer's disease, and complement. Int J Alzheimers Dis 2012, 983640.
-
(2012)
Int J Alzheimers Dis
, vol.2012
, pp. 983640
-
-
Crehan, H.1
Hardy, J.2
Pocock, J.3
-
7
-
-
84889664846
-
Candidate blood proteome markers of Alzheimer's disease onset and progression: A systematic review and replication study
-
Kiddle SJ, Sattlecker M, Proitsi P, Simmons A, Westman E, Bazenet C, Nelson SK, Williams S, Hodges A, Johnston C, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Newhouse S, Lovestone S, Dobson RJ (2014) Candidate blood proteome markers of Alzheimer's disease onset and progression: A systematic review and replication study. J Alzheimers Dis 38, 515-531.
-
(2014)
J Alzheimers Dis
, vol.38
, pp. 515-531
-
-
Kiddle, S.J.1
Sattlecker, M.2
Proitsi, P.3
Simmons, A.4
Westman, E.5
Bazenet, C.6
Nelson, S.K.7
Williams, S.8
Hodges, A.9
Johnston, C.10
Soininen, H.11
Kloszewska, I.12
Mecocci, P.13
Tsolaki, M.14
Vellas, B.15
Newhouse, S.16
Lovestone, S.17
Dobson, R.J.18
-
8
-
-
35948933394
-
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
-
Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 13, 1359-1362.
-
(2007)
Nat Med
, vol.13
, pp. 1359-1362
-
-
Ray, S.1
Britschgi, M.2
Herbert, C.3
Takeda-Uchimura, Y.4
Boxer, A.5
Blennow, K.6
Friedman, L.F.7
Galasko, D.R.8
Jutel, M.9
Karydas, A.10
Kaye, J.A.11
Leszek, J.12
Miller, B.L.13
Minthon, L.14
Quinn, J.F.15
Rabinovici, G.D.16
Robinson, W.H.17
Sabbagh, M.N.18
So, Y.T.19
Sparks, D.L.20
Tabaton, M.21
Tinklenberg, J.22
Yesavage, J.A.23
Tibshirani, R.24
Wyss-Coray, T.25
more..
-
9
-
-
84883288884
-
Evaluation of plasma proteomic data for Alzheimer disease state classification and for the prediction of progression from mild cognitive impairment to Alzheimer disease
-
Llano DA, Devanarayan V, Simon AJ, Alzheimer's Disease Neuroimaging I (2013) Evaluation of plasma proteomic data for Alzheimer disease state classification and for the prediction of progression from mild cognitive impairment to Alzheimer disease. Alzheimer Dis Assoc Disord 27, 233-243.
-
(2013)
Alzheimer Dis Assoc Disord
, vol.27
, pp. 233-243
-
-
Alzheimer's Disease Neuroimaging I.1
Llano, D.A.2
Devanarayan, V.3
Simon, A.J.4
-
10
-
-
84881483960
-
Serum proteomics in amnestic mild cognitive impairment
-
Ijsselstijn L, Papma JM, Dekker LJ, Calame W, Stingl C, Koudstaal PJ, Prins ND, Sillevis Smitt PA, Luider TM (2013) Serum proteomics in amnestic mild cognitive impairment. Proteomics 13, 2526-2533.
-
(2013)
Proteomics
, vol.13
, pp. 2526-2533
-
-
Ijsselstijn, L.1
Papma, J.M.2
Dekker, L.J.3
Calame, W.4
Stingl, C.5
Koudstaal, P.J.6
Prins, N.D.7
Sillevis Smitt, P.A.8
Luider, T.M.9
-
11
-
-
77954510398
-
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease
-
Thambisetty M, Simmons A,Velayudhan L, Hye A, Campbell J, Zhang Y, Wahlund LO, Westman E, Kinsey A, Guntert A, Proitsi P, Powell J, Causevic M, Killick R, Lunnon K, Lynham S, Broadstock M, Choudhry F, Howlett DR, Williams RJ, Sharp SI, Mitchelmore C, Tunnard C, Leung R, Foy C, O'Brien D, Breen G, Furney SJ, Ward M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Hodges A, Murphy DG, Parkins S, Richardson JC, Resnick SM, Ferrucci L, Wong DF, Zhou Y, Muehlboeck S, Evans A, Francis PT, Spenger C, Lovestone S (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry 67, 739-748.
-
(2010)
Arch Gen Psychiatry
, vol.67
, pp. 739-748
-
-
Thambisetty, M.1
Simmons, A.2
Velayudhan, L.3
Hye, A.4
Campbell, J.5
Zhang, Y.6
Wahlund, L.O.7
Westman, E.8
Kinsey, A.9
Guntert, A.10
Proitsi, P.11
Powell, J.12
Causevic, M.13
Killick, R.14
Lunnon, K.15
Lynham, S.16
Broadstock, M.17
Choudhry, F.18
Howlett, D.R.19
Williams, R.J.20
Sharp, S.I.21
Mitchelmore, C.22
Tunnard, C.23
Leung, R.24
Foy, C.25
O'brien, D.26
Breen, G.27
Furney, S.J.28
Ward, M.29
Kloszewska, I.30
Mecocci, P.31
Soininen, H.32
Tsolaki, M.33
Vellas, B.34
Hodges, A.35
Murphy, D.G.36
Parkins, S.37
Richardson, J.C.38
Resnick, S.M.39
Ferrucci, L.40
Wong, D.F.41
Zhou, Y.42
Muehlboeck, S.43
Evans, A.44
Francis, P.T.45
Spenger, C.46
Lovestone, S.47
more..
-
12
-
-
84866106602
-
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
-
Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM, Pickering E, Kuhn M, Chen Y, Van Deerlin VM, McCluskey L, Elman L, Karlawish J, Chen-Plotkin A, Hurtig HI, Siderowf A, Swenson F, Lee VM,Morris JC, Trojanowski JQ, Soares H, Alzheimer's Disease Neuroimaging I (2012) Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology 79, 897-905.
-
(2012)
Neurology
, vol.79
, pp. 897-905
-
-
Alzheimer's Disease Neuroimaging I.1
Hu, W.T.2
Holtzman, D.M.3
Fagan, A.M.4
Shaw, L.M.5
Perrin, R.6
Arnold, S.E.7
Grossman, M.8
Xiong, C.9
Craig-Schapiro, R.10
Clark, C.M.11
Pickering, E.12
Kuhn, M.13
Chen, Y.14
Van Deerlin, V.M.15
McCluskey, L.16
Elman, L.17
Karlawish, J.18
Chen-Plotkin, A.19
Hurtig, H.I.20
Siderowf, A.21
Swenson, F.22
Lee, V.M.23
Morris, J.C.24
Trojanowski, J.Q.25
Soares, H.26
more..
-
13
-
-
84867340530
-
Plasma biomarkers associated with the apolipoprotein e genotype and Alzheimer disease
-
Soares HD, Potter WZ, Pickering E, Kuhn M, Immermann FW, Shera DM, Ferm M, Dean RA, Simon AJ, Swenson F, Siuciak JA, Kaplow J, Thambisetty M, Zagouras P, Koroshetz WJ, Wan HI, Trojanowski JQ, Shaw LM, Biomarkers Consortium Alzheimer's Disease Plasma Proteomics P (2012) Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch Neurol 69, 1310-1317.
-
(2012)
Arch Neurol
, vol.69
, pp. 1310-1317
-
-
Biomarkers Consortium Alzheimer's Disease Plasma Proteomics P1
Soares, H.D.2
Potter, W.Z.3
Pickering, E.4
Kuhn, M.5
Immermann, F.W.6
Shera, D.M.7
Ferm, M.8
Dean, R.A.9
Simon, A.J.10
Swenson, F.11
Siuciak, J.A.12
Kaplow, J.13
Thambisetty, M.14
Zagouras, P.15
Koroshetz, W.J.16
Wan, H.I.17
Trojanowski, J.Q.18
Shaw, L.M.19
-
14
-
-
84867392697
-
Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics
-
Cocciolo A, Di Domenico F, Coccia R, Fiorini A, Cai J, Pierce WM,Mecocci P, ButterfieldDA, PerluigiM(2012) Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics. Free Radic Biol Med 53, 1868-1876.
-
(2012)
Free Radic Biol Med
, vol.53
, pp. 1868-1876
-
-
Cocciolo, A.1
Di Domenico, F.2
Coccia, R.3
Fiorini, A.4
Cai, J.5
Pierce, W.M.6
Mecocci, P.7
Butterfield, D.A.8
Perluigi, M.9
-
15
-
-
84892459182
-
Plasma protein profiling of mild cognitive impairment and Alzheimer's disease using iTRAQ quantitative proteomics
-
Song F, Poljak A, Kochan N, Raftery M, Brodaty H, Smythe G, Sachdev P (2014) Plasma protein profiling of mild cognitive impairment and Alzheimer's disease using iTRAQ quantitative proteomics. Proteome Sci 12, 5.
-
(2014)
Proteome Sci
, vol.12
, pp. 5
-
-
Song, F.1
Poljak, A.2
Kochan, N.3
Raftery, M.4
Brodaty, H.5
Smythe, G.6
Sachdev, P.7
-
16
-
-
77956410251
-
Cohort profile: The Hunter Community Study
-
McEvoy M, Smith W, D'Este C, Duke J, Peel R, Schofield P, Scott R, Byles J, Henry D, Ewald B, Hancock S, Smith D, Attia J (2010) Cohort profile: The Hunter Community Study. Int J Epidemiol 39, 1452-1463.
-
(2010)
Int J Epidemiol
, vol.39
, pp. 1452-1463
-
-
McEvoy, M.1
Smith, W.2
D'este, C.3
Duke, J.4
Peel, R.5
Schofield, P.6
Scott, R.7
Byles, J.8
Henry, D.9
Ewald, B.10
Hancock, S.11
Smith, D.12
Attia, J.13
-
17
-
-
79952199669
-
The SydneyMemory and Ageing Study (MAS): Methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years
-
Sachdev PS, Brodaty H, Reppermund S, Kochan NA, Trollor JN, Draper B, Slavin MJ, Crawford J, Kang K, Broe GA, Mather KA, Lux O, Memory, Ageing Study T (2010) The SydneyMemory and Ageing Study (MAS): Methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int Psychogeriatr 22, 1248-1264.
-
(2010)
Int Psychogeriatr
, vol.22
, pp. 1248-1264
-
-
Memory, Ageing Study T,1
Sachdev, P.S.2
Brodaty, H.3
Reppermund, S.4
Kochan, N.A.5
Trollor, J.N.6
Draper, B.7
Slavin, M.J.8
Crawford, J.9
Kang, K.10
Broe, G.A.11
Mather, K.A.12
Lux, O.13
-
18
-
-
77953720014
-
The Audio Recorded Cognitive Screen (ARCS): A flexible hybrid cognitive test instrument
-
Schofield PW, Lee SJ, Lewin TJ, Lyall G, Moyle J, Attia J, McEvoy M (2010) The Audio Recorded Cognitive Screen (ARCS): A flexible hybrid cognitive test instrument. J Neurol Neurosurg Psychiatry 81, 602-607.
-
(2010)
J Neurol Neurosurg Psychiatry
, vol.81
, pp. 602-607
-
-
Schofield, P.W.1
Lee, S.J.2
Lewin, T.J.3
Lyall, G.4
Moyle, J.5
Attia, J.6
McEvoy, M.7
-
19
-
-
4544350756
-
Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment
-
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240-246.
-
(2004)
J Intern Med
, vol.256
, pp. 240-246
-
-
Winblad, B.1
Palmer, K.2
Kivipelto, M.3
Jelic, V.4
Fratiglioni, L.5
Wahlund, L.O.6
Nordberg, A.7
Backman, L.8
Albert, M.9
Almkvist, O.10
Arai, H.11
Basun, H.12
Blennow, K.13
De Leon, M.14
Decarli, C.15
Erkinjuntti, T.16
Giacobini, E.17
Graff, C.18
Hardy, J.19
Jack, C.20
Jorm, A.21
Ritchie, K.22
Van Duijn, C.23
Visser, P.24
Petersen, R.C.25
more..
-
20
-
-
0031842242
-
The Bayer Activities of Daily Living Scale (B-ADL)
-
Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H (1998) The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord 9(Suppl 2), 20-26.
-
(1998)
Dement Geriatr Cogn Disord
, vol.9
, pp. 20-26
-
-
Hindmarch, I.1
Lehfeld, H.2
De Jongh, P.3
Erzigkeit, H.4
-
21
-
-
77951044468
-
Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction
-
Lim YA, Rhein V, Baysang G, Meier F, Poljak A, Raftery MJ, Guilhaus M, Ittner LM, Eckert A, Gotz J (2010) Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction. Proteomics 10, 1621-1633.
-
(2010)
Proteomics
, vol.10
, pp. 1621-1633
-
-
Lim, Y.A.1
Rhein, V.2
Baysang, G.3
Meier, F.4
Poljak, A.5
Raftery, M.J.6
Guilhaus, M.7
Ittner, L.M.8
Eckert, A.9
Gotz, J.10
-
22
-
-
76149128021
-
Global proteomic analysis of the insoluble, soluble, and supernatant fractions of the psychrophilic archaeon Methanococcoides burtonii. Part II: The effect of different methylated growth substrates
-
Williams TJ, Burg DW, Ertan H, Raftery MJ, Poljak A, Guilhaus M, Cavicchioli R (2010) Global proteomic analysis of the insoluble, soluble, and supernatant fractions of the psychrophilic archaeon Methanococcoides burtonii. Part II: The effect of different methylated growth substrates. J Proteome Res 9, 653-663.
-
(2010)
J Proteome Res
, vol.9
, pp. 653-663
-
-
Williams, T.J.1
Burg, D.W.2
Ertan, H.3
Raftery, M.J.4
Poljak, A.5
Guilhaus, M.6
Cavicchioli, R.7
-
23
-
-
84876515907
-
STRINGv9.1: Protein-protein interaction networks, with increased coverage and integration
-
Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, Jensen LJ (2013)STRINGv9.1: Protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41, D808-815.
-
(2013)
Nucleic Acids Res
, vol.41
, pp. D808-815
-
-
Franceschini, A.1
Szklarczyk, D.2
Frankild, S.3
Kuhn, M.4
Simonovic, M.5
Roth, A.6
Lin, J.7
Minguez, P.8
Bork, P.9
Von Mering, C.10
Jensen, L.J.11
-
24
-
-
79959499115
-
A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas
-
M110 006353
-
Farrah T, Deutsch EW, Omenn GS, Campbell DS, Sun Z, Bletz JA, Mallick P, Katz JE, Malmstrom J, Ossola R, Watts JD, Lin B, Zhang H, Moritz RL, Aebersold R (2011) A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics 10, M110 006353.
-
(2011)
Mol Cell Proteomics
, vol.10
-
-
Farrah, T.1
Deutsch, E.W.2
Omenn, G.S.3
Campbell, D.S.4
Sun, Z.5
Bletz, J.A.6
Mallick, P.7
Katz, J.E.8
Malmstrom, J.9
Ossola, R.10
Watts, J.D.11
Lin, B.12
Zhang, H.13
Moritz, R.L.14
Aebersold, R.15
-
25
-
-
79959937286
-
New insights into the altered fibronectin matrix and extrasynaptic transmission in the ageing brain
-
Wang J, TYin L, Chen Z (2011) New insights into the altered fibronectin matrix and extrasynaptic transmission in the ageing brain. J Clini Gerontol Geriatr 2, 35-41.
-
(2011)
J Clini Gerontol Geriatr
, vol.2
, pp. 35-41
-
-
Wang, J.1
Tyin, L.2
Chen, Z.3
-
26
-
-
70350426110
-
Molecular status of plasma fibronectin as an additional biomarker for assessment of Alzheimer's dementia risk
-
Lemanska-Perek A, Leszek J, Krzyzanowska-Golab D, Radzik J, Katnik-Prastowska I (2009) Molecular status of plasma fibronectin as an additional biomarker for assessment of Alzheimer's dementia risk. Dement Geriatr Cogn Disord 28, 338-342.
-
(2009)
Dement Geriatr Cogn Disord
, vol.28
, pp. 338-342
-
-
Lemanska-Perek, A.1
Leszek, J.2
Krzyzanowska-Golab, D.3
Radzik, J.4
Katnik-Prastowska, I.5
-
27
-
-
0028989637
-
Alzheimer's-associated phospho-tau epitope in human neuroblastoma cell cultures: Up-regulation by fibronectin and laminin
-
Martin H, Lambert MP, Barber K, Hinton S, KleinWL(1995) Alzheimer's-associated phospho-tau epitope in human neuroblastoma cell cultures: Up-regulation by fibronectin and laminin. Neuroscience 66, 769-779.
-
(1995)
Neuroscience
, vol.66
, pp. 769-779
-
-
Martin, H.1
Lambert, M.P.2
Barber, K.3
Hinton, S.4
Klein, W.L.5
-
28
-
-
54249150387
-
Identification of fibronectin type i domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs
-
Maas C, Schiks B, Strangi RD, Hackeng TM, Bouma BN, Gebbink MF, Bouma B (2008) Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs. Amyloid 15, 166-180.
-
(2008)
Amyloid
, vol.15
, pp. 166-180
-
-
Maas, C.1
Schiks, B.2
Strangi, R.D.3
Hackeng, T.M.4
Bouma, B.N.5
Gebbink, M.F.6
Bouma, B.7
-
29
-
-
79954623282
-
Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy
-
Hawkes CA, Hartig W, Kacza J, Schliebs R, Weller RO, Nicoll JA, Carare RO (2011) Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol 121, 431-443.
-
(2011)
Acta Neuropathol
, vol.121
, pp. 431-443
-
-
Hawkes, C.A.1
Hartig, W.2
Kacza, J.3
Schliebs, R.4
Weller, R.O.5
Nicoll, J.A.6
Carare, R.O.7
-
30
-
-
84871371241
-
Presenilin-1 regulates the constitutive turnover of the fibronectin matrix in endothelial cells
-
De Gasperi R, Sosa MAG, Elder GA (2012) Presenilin-1 regulates the constitutive turnover of the fibronectin matrix in endothelial cells. BMC Biochem 13, 28.
-
(2012)
BMC Biochem
, vol.13
, pp. 28
-
-
De Gasperi, R.1
Sosa, M.A.G.2
Elder, G.A.3
-
31
-
-
77957345937
-
Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease
-
Guntert A, Campbell J, Saleem M, O'Brien DP, Thompson AJ, Byers HL,Ward MA, Lovestone S (2010) Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease. J Alzheimers Dis 21, 585-596.
-
(2010)
J Alzheimers Dis
, vol.21
, pp. 585-596
-
-
Guntert, A.1
Campbell, J.2
Saleem, M.3
O'brien, D.P.4
Thompson, A.J.5
Byers, H.L.6
Ward, M.A.7
Lovestone, S.8
-
32
-
-
84927178738
-
Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology
-
Sattlecker M, Kiddle SJ, Newhouse S, Proitsi P, Nelson S, Williams S, Johnston C, Killick R, Simmons A, Westman E, Hodges A, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, the AddNeuroMed C, Dobson RJ (2014) Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimers Dement. doi: 10.1016/j.jalz.2013.09.016
-
(2014)
Alzheimers Dement.
-
-
Sattlecker, M.1
Kiddle, S.J.2
Newhouse, S.3
Proitsi, P.4
Nelson, S.5
Williams, S.6
Johnston, C.7
Killick, R.8
Simmons, A.9
Westman, E.10
Hodges, A.11
Soininen, H.12
Kloszewska, I.13
Mecocci, P.14
Tsolaki, M.15
Vellas, B.16
Lovestone, S.17
The Addneuromed, C.18
Dobson, R.J.19
-
33
-
-
38449091610
-
Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease
-
Liao PC, Yu L, Kuo CC, Lin C, Kuo YM (2007) Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease. Proteomics Clin Appl 1, 506-512.
-
(2007)
Proteomics Clin Appl
, vol.1
, pp. 506-512
-
-
Liao, P.C.1
Yu, L.2
Kuo, C.C.3
Lin, C.4
Kuo, Y.M.5
-
34
-
-
33747409456
-
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders
-
Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, Jin J, Zhu D, Li GJ, Liu Y, Waichunas D, Montine TJ, Zhang J (2006) Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis 9, 293-348.
-
(2006)
J Alzheimers Dis
, vol.9
, pp. 293-348
-
-
Abdi, F.1
Quinn, J.F.2
Jankovic, J.3
McIntosh, M.4
Leverenz, J.B.5
Peskind, E.6
Nixon, R.7
Nutt, J.8
Chung, K.9
Zabetian, C.10
Samii, A.11
Lin, M.12
Hattan, S.13
Pan, C.14
Wang, Y.15
Jin, J.16
Zhu, D.17
Li, G.J.18
Liu, Y.19
Waichunas, D.20
Montine, T.J.21
Zhang, J.22
more..
-
35
-
-
33847665648
-
Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease
-
Finehout EJ, Franck Z, Choe LH, Relkin N, Lee KH (2007) Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. Ann Neurol 61, 120-129.
-
(2007)
Ann Neurol
, vol.61
, pp. 120-129
-
-
Finehout, E.J.1
Franck, Z.2
Choe, L.H.3
Relkin, N.4
Lee, K.H.5
-
36
-
-
84861507856
-
Assessing candidate serum biomarkers for Alzheimer's disease: A longitudinal study
-
Zabel M, Schrag M, Mueller C, Zhou WD, Crofton A, Petersen F, Dickson A, Kirsch WM (2012) Assessing candidate serum biomarkers for Alzheimer's disease: A longitudinal study. J Alzheimers Dis 30, 311-321.
-
(2012)
J Alzheimers Dis
, vol.30
, pp. 311-321
-
-
Zabel, M.1
Schrag, M.2
Mueller, C.3
Zhou, W.D.4
Crofton, A.5
Petersen, F.6
Dickson, A.7
Kirsch, W.M.8
-
37
-
-
84865382853
-
New perspectives on the vitamin D binding protein
-
Chun RF (2012) New perspectives on the vitamin D binding protein. Cell Biochem Funct 30, 445-456.
-
(2012)
Cell Biochem Funct
, vol.30
, pp. 445-456
-
-
Chun, R.F.1
-
38
-
-
84876532197
-
The role of vitamin D in Alzheimer's disease: Possible genetic and cell signaling mechanisms
-
Lu'o'ng KV, Nguyen LT (2013) The role of vitamin D in Alzheimer's disease: Possible genetic and cell signaling mechanisms. Am J Alzheimers Dis Other Demen 28, 126-136.
-
(2013)
Am J Alzheimers Dis Other Demen
, vol.28
, pp. 126-136
-
-
Lu'o'ng, K.V.1
Nguyen, L.T.2
-
39
-
-
81255135921
-
Vitamin D in the healthy and inflamed central nervous system: Access and function
-
Smolders J, Moen SM, Damoiseaux J, Huitinga I, Holmoy T (2011) Vitamin D in the healthy and inflamed central nervous system: Access and function. J Neurol Sci 311, 37-43.
-
(2011)
J Neurol Sci
, vol.311
, pp. 37-43
-
-
Smolders, J.1
Moen, S.M.2
Damoiseaux, J.3
Huitinga, I.4
Holmoy, T.5
-
40
-
-
84874945336
-
Vitamin D-binding protein interacts with A beta and suppresses A beta-mediated pathology
-
Moon M, Song H, Hong HJ, NamDW, ChaMY,OhMS,Yu J, Ryu H, Mook-Jung I (2013) Vitamin D-binding protein interacts with A beta and suppresses A beta-mediated pathology. Cell Death Differ 20, 630-638.
-
(2013)
Cell Death Differ
, vol.20
, pp. 630-638
-
-
Moon, M.1
Song, H.2
Hong, H.J.3
Nam, D.W.4
Cha, M.Y.5
Oh, M.S.6
Yu, J.7
Ryu, H.8
Mook-Jung, I.9
-
41
-
-
0036400025
-
Ceruloplasmin metabolism and function
-
Hellman NE, Gitlin JD (2002) Ceruloplasmin metabolism and function. Annu Rev Nutr 22, 439-458.
-
(2002)
Annu Rev Nutr
, vol.22
, pp. 439-458
-
-
Hellman, N.E.1
Gitlin, J.D.2
-
42
-
-
0036703490
-
Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury
-
Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien JP, David S (2002) Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci 22, 6578-6586.
-
(2002)
J Neurosci
, vol.22
, pp. 6578-6586
-
-
Patel, B.N.1
Dunn, R.J.2
Jeong, S.Y.3
Zhu, Q.4
Julien, J.P.5
David, S.6
-
45
-
-
0023847698
-
Acute-phase proteins in Alzheimer's disease
-
Giometto B, Argentiero V, Sanson F, Ongaro G, Tavolato B (1988) Acute-phase proteins in Alzheimer's disease. Eur Neurol 28, 30-33.
-
(1988)
Eur Neurol
, vol.28
, pp. 30-33
-
-
Giometto, B.1
Argentiero, V.2
Sanson, F.3
Ongaro, G.4
Tavolato, B.5
-
46
-
-
33750463720
-
Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease
-
Kessler H, Pajonk FG, Meisser P, Schneider-Axmann T, Hoffmann KH, Supprian T, Herrmann W, Obeid R, Multhaup G, Falkai P, Bayer TA (2006) Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease. J Neural Transm 113, 1763-1769.
-
(2006)
J Neural Transm
, vol.113
, pp. 1763-1769
-
-
Kessler, H.1
Pajonk, F.G.2
Meisser, P.3
Schneider-Axmann, T.4
Hoffmann, K.H.5
Supprian, T.6
Herrmann, W.7
Obeid, R.8
Multhaup, G.9
Falkai, P.10
Bayer, T.A.11
-
47
-
-
84894309053
-
Elevated serum copper and ceruloplasmin levels in Alzheimer's disease
-
Park JH, Lee DW, Park KS (2014) Elevated serum copper and ceruloplasmin levels in Alzheimer's disease. Asia Pac Psychiatry 6, 38-45.
-
(2014)
Asia Pac Psychiatry
, vol.6
, pp. 38-45
-
-
Park, J.H.1
Lee, D.W.2
Park, K.S.3
-
48
-
-
84874293434
-
Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease
-
Rembach A, Doecke JD, Roberts BR, Watt AD, Faux NG, Volitakis I, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, WilsonW, Ellis KA, Martins RN, Rowe CC, Villemagne VL, Ames D, Masters CL, Bush AI, Grp AR (2013) Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease. J Alzheimers Dis 34, 171-182.
-
(2013)
J Alzheimers Dis
, vol.34
, pp. 171-182
-
-
Rembach, A.1
Doecke, J.D.2
Roberts, B.R.3
Watt, A.D.4
Faux, N.G.5
Volitakis, I.6
Pertile, K.K.7
Rumble, R.L.8
Trounson, B.O.9
Fowler, C.J.10
Wilson, W.11
Ellis, K.A.12
Martins, R.N.13
Rowe, C.C.14
Villemagne, V.L.15
Ames, D.16
Masters, C.L.17
Bush, A.I.18
Grp, A.R.19
-
49
-
-
42449142396
-
Proteomic identification and early validation of complement 1 inhibitor and pigment epitheliumderived factor: Two novel biomarkers of Alzheimer's disease in human plasma
-
Cutler P, Akuffo EL, Bodnar WM, Briggs DM, Davis JB, Debouck CM, Fox SM, Gibson RA, Gormley DA, Holbrook JD, Hunter AJ, Kinsey EE, Prinjha R, Richardson JC, Roses AD, Smith MA, Tsokanas N, Wille DR, Wu W, Yates JW, Gloger IS (2008) Proteomic identification and early validation of complement 1 inhibitor and pigment epitheliumderived factor: Two novel biomarkers of Alzheimer's disease in human plasma. Proteomics Clin Appl 2, 467-477.
-
(2008)
Proteomics Clin Appl
, vol.2
, pp. 467-477
-
-
Cutler, P.1
Akuffo, E.L.2
Bodnar, W.M.3
Briggs, D.M.4
Davis, J.B.5
Debouck, C.M.6
Fox, S.M.7
Gibson, R.A.8
Gormley, D.A.9
Holbrook, J.D.10
Hunter, A.J.11
Kinsey, E.E.12
Prinjha, R.13
Richardson, J.C.14
Roses, A.D.15
Smith, M.A.16
Tsokanas, N.17
Wille, D.R.18
Wu, W.19
Yates, J.W.20
Gloger, I.S.21
more..
-
50
-
-
0028986014
-
Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: An acute phase reactant without the peripheral acute phase response
-
Licastro F, Morini MC, Polazzi E, Davis LJ (1995) Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: An acute phase reactant without the peripheral acute phase response. J Neuroimmunol 57, 71-75.
-
(1995)
J Neuroimmunol
, vol.57
, pp. 71-75
-
-
Licastro, F.1
Morini, M.C.2
Polazzi, E.3
Davis, L.J.4
-
51
-
-
36749090530
-
'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function
-
Squitti R, Ventriglia M, Barbati G, Cassetta E, Ferreri F, Dal Forno G, Ramires S, Zappasodi F, Rossini PM (2007) 'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function. J Neural Transm 114, 1589-1594.
-
(2007)
J Neural Transm
, vol.114
, pp. 1589-1594
-
-
Squitti, R.1
Ventriglia, M.2
Barbati, G.3
Cassetta, E.4
Ferreri, F.5
Dal Forno, G.6
Ramires, S.7
Zappasodi, F.8
Rossini, P.M.9
-
52
-
-
70449512334
-
A study of serum copper and ceruloplasmin in Alzheimer's disease in Kerman, Iran
-
Sedighi BS, Shafa MA, Shariat M (2006) A study of serum copper and ceruloplasmin in Alzheimer's disease in Kerman, Iran. Neurol Asia 11, 107-109.
-
(2006)
Neurol Asia
, vol.11
, pp. 107-109
-
-
Sedighi, B.S.1
Shafa, M.A.2
Shariat, M.3
-
53
-
-
77956489889
-
Copper and ceruloplasmin abnormalities in Alzheimer's disease
-
Brewer GJ, Kanzer SH, Zimmerman EA, Celmins DF, Heckman SM, Dick R (2010) Copper and ceruloplasmin abnormalities in Alzheimer's disease. Am J Alzheimers Dis Other Demen 25, 490-497.
-
(2010)
Am J Alzheimers Dis Other Demen
, vol.25
, pp. 490-497
-
-
Brewer, G.J.1
Kanzer, S.H.2
Zimmerman, E.A.3
Celmins, D.F.4
Heckman, S.M.5
Dick, R.6
-
54
-
-
0031847561
-
Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease a case-control study
-
Snaedal J, Kristinsson J, Gunnarsdottir S, Olafsdottir, Baldvinsson M, Johannesson T (1998) Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease. a case-control study. Dement Geriatr Cogn Disord 9, 239-242.
-
(1998)
Dement Geriatr Cogn Disord
, vol.9
, pp. 239-242
-
-
Snaedal, J.1
Kristinsson, J.2
Gunnarsdottir, S.3
Olafsdottir4
Baldvinsson, M.5
Johannesson, T.6
-
55
-
-
84867478094
-
Ceruloplasmin and iron proteins in the serum of patients with Alzheimer's disease
-
Torsdottir G, Kristinsson J, Snaedal J, Johannesson T (2011) Ceruloplasmin and iron proteins in the serum of patients with Alzheimer's disease. Dement Geriatr Cogn Dis Extra 1, 366-371.
-
(2011)
Dement Geriatr Cogn Dis Extra
, vol.1
, pp. 366-371
-
-
Torsdottir, G.1
Kristinsson, J.2
Snaedal, J.3
Johannesson, T.4
-
56
-
-
79960887486
-
Systemic inflammation and Alzheimer's disease
-
Holmes C, Butchart J (2011) Systemic inflammation and Alzheimer's disease. Biochem Soc Trans 39, 898-901.
-
(2011)
Biochem Soc Trans
, vol.39
, pp. 898-901
-
-
Holmes, C.1
Butchart, J.2
-
57
-
-
84855260469
-
Complement activation as a biomarker for Alzheimer's disease
-
AiyazM,LuptonMK,Proitsi P, Powell JF,Lovestone S (2012) Complement activation as a biomarker for Alzheimer's disease. Immunobiology 217, 204-215.
-
(2012)
Immunobiology
, vol.217
, pp. 204-215
-
-
Aiyaz, M.1
Lupton, M.K.2
Proitsi, P.3
Powell, J.F.4
Lovestone, S.5
-
59
-
-
0034734786
-
Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain
-
Strohmeyer R, Shen Y, Rogers J (2000) Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain. Brain Res Mol Brain Res 81, 7-18.
-
(2000)
Brain Res Mol Brain Res
, vol.81
, pp. 7-18
-
-
Strohmeyer, R.1
Shen, Y.2
Rogers, J.3
-
60
-
-
84868089393
-
Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain
-
Lukiw WJ, Alexandrov PN(2012) Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol Neurobiol 46, 11-19.
-
(2012)
Mol Neurobiol
, vol.46
, pp. 11-19
-
-
Lukiw, W.J.1
Alexandrov, P.N.2
-
61
-
-
46749123000
-
C4b-binding protein in Alzheimer's disease: Binding to Abeta1-42 and to dead cells
-
Trouw LA, Nielsen HM, Minthon L, Londos E, Landberg G, Veerhuis R, Janciauskiene S, Blom AM (2008) C4b-binding protein in Alzheimer's disease: Binding to Abeta1-42 and to dead cells. Mol Immunol 45, 3649-3660.
-
(2008)
Mol Immunol
, vol.45
, pp. 3649-3660
-
-
Trouw, L.A.1
Nielsen, H.M.2
Minthon, L.3
Londos, E.4
Landberg, G.5
Veerhuis, R.6
Janciauskiene, S.7
Blom, A.M.8
-
62
-
-
84883187048
-
BDNF, TNFalpha, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment
-
Gezen-Ak D, Dursun E, Hanagasi H, Bilgic B, Lohman E, Araz OS, Atasoy I, Alaylioglu M, Onal B, Gurvit H, Yilmazer S (2013) BDNF, TNFalpha, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment. J Alzheimers Dis 37, 185-195.
-
(2013)
J Alzheimers Dis
, vol.37
, pp. 185-195
-
-
Gezen-Ak, D.1
Dursun, E.2
Hanagasi, H.3
Bilgic, B.4
Lohman, E.5
Araz, O.S.6
Atasoy, I.7
Alaylioglu, M.8
Onal, B.9
Gurvit, H.10
Yilmazer, S.11
-
63
-
-
58549087156
-
Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease
-
Thambisetty M, Hye A, Foy C, Daly E, Glover A, Cooper A, Simmons A, Murphy D, Lovestone S (2008) Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease. J Neurol 255, 1712-1720.
-
(2008)
J Neurol
, vol.255
, pp. 1712-1720
-
-
Thambisetty, M.1
Hye, A.2
Foy, C.3
Daly, E.4
Glover, A.5
Cooper, A.6
Simmons, A.7
Murphy, D.8
Lovestone, S.9
-
64
-
-
0942276226
-
Mining biomarkers in human sera using proteomic tools
-
Zhang R, Barker L, Pinchev D, Marshall J, Rasamoelisolo M, Smith C, Kupchak P, Kireeva I, Ingratta L, Jackowski G (2004) Mining biomarkers in human sera using proteomic tools. Proteomics 4, 244-256.
-
(2004)
Proteomics
, vol.4
, pp. 244-256
-
-
Zhang, R.1
Barker, L.2
Pinchev, D.3
Marshall, J.4
Rasamoelisolo, M.5
Smith, C.6
Kupchak, P.7
Kireeva, I.8
Ingratta, L.9
Jackowski, G.10
-
65
-
-
17544395986
-
Inhibition of C1q-beta-amyloid binding protects hippocampal cells against complement mediated toxicity
-
Sarvari M, Vago I,Weber CS, Nagy J, Gal P, MakM, Kosa JP, Zavodszky P, Pazmany T (2003) Inhibition of C1q-beta-amyloid binding protects hippocampal cells against complement mediated toxicity. J Neuroimmunol 137, 12-18.
-
(2003)
J Neuroimmunol
, vol.137
, pp. 12-18
-
-
Sarvari, M.1
Vago, I.2
Weber, C.S.3
Nagy, J.4
Gal, P.5
Mak, M.6
Kosa, J.P.7
Zavodszky, P.8
Pazmany, T.9
-
66
-
-
0032710620
-
Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor
-
Veerhuis R, Janssen I, De Groot CJ,Van Muiswinkel FL, Hack CE, Eikelenboom P (1999) Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Exp Neurol 160, 289-299.
-
(1999)
Exp Neurol
, vol.160
, pp. 289-299
-
-
Veerhuis, R.1
Janssen, I.2
De Groot, C.J.3
Van Muiswinkel, F.L.4
Hack, C.E.5
Eikelenboom, P.6
-
67
-
-
0031691401
-
Complement C1-inhibitor expression in Alzheimer's disease
-
Veerhuis R, Janssen I, Hoozemans JJ, De Groot CJ, Hack CE, Eikelenboom P (1998) Complement C1-inhibitor expression in Alzheimer's disease. Acta Neuropathol 96, 287-296.
-
(1998)
Acta Neuropathol
, vol.96
, pp. 287-296
-
-
Veerhuis, R.1
Janssen, I.2
Hoozemans, J.J.3
De Groot, C.J.4
Hack, C.E.5
Eikelenboom, P.6
-
68
-
-
21044455621
-
Complement protein isoforms in CSF as possible biomarkers for neurodegenerative disease
-
Finehout EJ, Franck Z, Lee KH (2005) Complement protein isoforms in CSF as possible biomarkers for neurodegenerative disease. Dis Markers 21, 93-101.
-
(2005)
Dis Markers
, vol.21
, pp. 93-101
-
-
Finehout, E.J.1
Franck, Z.2
Lee, K.H.3
-
69
-
-
0033977654
-
Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system
-
Jongen PJ, Doesburg WH, Ibrahim-Stappers JL, Lemmens WA, Hommes OR, Lamers KJ (2000) Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system. Acta Neurol Scand 101, 116-121.
-
(2000)
Acta Neurol Scand
, vol.101
, pp. 116-121
-
-
Jongen, P.J.1
Doesburg, W.H.2
Ibrahim-Stappers, J.L.3
Lemmens, W.A.4
Hommes, O.R.5
Lamers, K.J.6
-
71
-
-
79953747266
-
Plasma clusterin and the risk of Alzheimer disease
-
Schrijvers EM,Koudstaal PJ, Hofman A, BretelerMM(2011) Plasma clusterin and the risk of Alzheimer disease. JAMA305, 1322-1326.
-
(2011)
JAMA
, vol.305
, pp. 1322-1326
-
-
Schrijvers, E.M.1
Koudstaal, P.J.2
Hofman, A.3
Breteler, M.M.4
-
72
-
-
84862174192
-
Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals
-
Song F, Poljak A, Crawford J, Kochan NA,WenW, Cameron B, Lux O, Brodaty H, Mather K, Smythe GA, Sachdev PS (2012) Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals. PLoS One 7, e34078.
-
(2012)
PLoS One
, vol.7
-
-
Song, F.1
Poljak, A.2
Crawford, J.3
Kochan, N.A.4
Wen, W.5
Cameron, B.6
Lux, O.7
Brodaty, H.8
Mather, K.9
Smythe, G.A.10
Sachdev, P.S.11
-
73
-
-
80054107095
-
Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment
-
Thambisetty M, An Y, Kinsey A, Koka D, Saleem M, Guntert A, Kraut M, Ferrucci L, Davatzikos C, Lovestone S, Resnick SM (2012) Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. Neuroimage 59, 212-217.
-
(2012)
Neuroimage
, vol.59
, pp. 212-217
-
-
Thambisetty, M.1
An, Y.2
Kinsey, A.3
Koka, D.4
Saleem, M.5
Guntert, A.6
Kraut, M.7
Ferrucci, L.8
Davatzikos, C.9
Lovestone, S.10
Resnick, S.M.11
-
74
-
-
84871420957
-
Finding a pathological diagnosis for Alzheimer's disease: Are inflammatory molecules the answer?
-
Bhamra MS, Ashton NJ (2012) Finding a pathological diagnosis for Alzheimer's disease: Are inflammatory molecules the answer? Electrophoresis 33, 3598-3607.
-
(2012)
Electrophoresis
, vol.33
, pp. 3598-3607
-
-
Bhamra, M.S.1
Ashton, N.J.2
-
75
-
-
84872230307
-
Fibrinogen and altered hemostasis in Alzheimer's disease
-
Cortes-Canteli M, Zamolodchikov D, Ahn HJ, Strickland S, Norris EH (2012) Fibrinogen and altered hemostasis in Alzheimer's disease. J Alzheimers Dis 32, 599-608.
-
(2012)
J Alzheimers Dis
, vol.32
, pp. 599-608
-
-
Cortes-Canteli, M.1
Zamolodchikov, D.2
Ahn, H.J.3
Strickland, S.4
Norris, E.H.5
-
76
-
-
84861910177
-
Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease
-
Giambattistelli F, Bucossi S, Salustri C, Panetta V, Mariani S, Siotto M, Ventriglia M, Vernieri F, Dell'acqua ML, Cassetta E, Rossini PM, Squitti R (2012) Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease. Neurobiol Aging 33, 1633-1641.
-
(2012)
Neurobiol Aging
, vol.33
, pp. 1633-1641
-
-
Giambattistelli, F.1
Bucossi, S.2
Salustri, C.3
Panetta, V.4
Mariani, S.5
Siotto, M.6
Ventriglia, M.7
Vernieri, F.8
Dell'acqua, M.L.9
Cassetta, E.10
Rossini, P.M.11
Squitti, R.12
-
77
-
-
44849095467
-
Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment
-
Xu G, Zhang H, Zhang S, FanX, LiuX(2008) Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment. Int J Clin Pract 62, 1070-1075.
-
(2008)
Int J Clin Pract
, vol.62
, pp. 1070-1075
-
-
Xu, G.1
Zhang, H.2
Zhang, S.3
Fan, X.4
Liu, X.5
-
78
-
-
33644663637
-
Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia
-
van Oijen M,Witteman JC, Hofman A,Koudstaal PJ, Breteler MM (2005) Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke 36, 2637-2641.
-
(2005)
Stroke
, vol.36
, pp. 2637-2641
-
-
Van Oijen, M.1
Witteman, J.C.2
Hofman, A.3
Koudstaal, P.J.4
Breteler, M.M.5
-
79
-
-
83755185924
-
Plasma biomarkers of brain atrophy in Alzheimer's disease
-
Thambisetty M, Simmons A, Hye A, Campbell J, Westman E, Zhang Y, Wahlund LO, Kinsey A, Causevic M, Killick R, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S, AddNeuroMed C (2011) Plasma biomarkers of brain atrophy in Alzheimer's disease. PLoS One 6, e28527.
-
(2011)
PLoS One
, vol.6
-
-
Thambisetty, M.1
Simmons, A.2
Hye, A.3
Campbell, J.4
Westman, E.5
Zhang, Y.6
Wahlund, L.O.7
Kinsey, A.8
Causevic, M.9
Killick, R.10
Kloszewska, I.11
Mecocci, P.12
Soininen, H.13
Tsolaki, M.14
Vellas, B.15
Spenger, C.16
Lovestone, S.17
Addneuromed, C.18
-
80
-
-
79955431733
-
Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis
-
Craig-Schapiro R, Kuhn M, Xiong C, Pickering EH, Liu J, Misko TP, Perrin RJ, Bales KR, Soares H, Fagan AM, Holtzman DM (2011) Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis. PLoS One 6, e18850.
-
(2011)
PLoS One
, vol.6
-
-
Craig-Schapiro, R.1
Kuhn, M.2
Xiong, C.3
Pickering, E.H.4
Liu, J.5
Misko, T.P.6
Perrin, R.J.7
Bales, K.R.8
Soares, H.9
Fagan, A.M.10
Holtzman, D.M.11
-
81
-
-
34347407998
-
Fibrinogen gamma-A chain precursor in CSF: A candidate biomarker for Alzheimer's disease
-
Lee JW, Namkoong H, Kim HK, Kim S, Hwang DW, Na HR, Ha SA, Kim JR, Kim JW (2007) Fibrinogen gamma-A chain precursor in CSF: A candidate biomarker for Alzheimer's disease. BMC Neurol 7, 14.
-
(2007)
BMC Neurol
, vol.7
, pp. 14
-
-
Lee, J.W.1
Namkoong, H.2
Kim, H.K.3
Kim, S.4
Hwang, D.W.5
Na, H.R.6
Ha, S.A.7
Kim, J.R.8
Kim, J.W.9
-
82
-
-
84863229780
-
Identification of SPARClike 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid
-
Vafadar-Isfahani B, Ball G, Coveney C, Lemetre C, Boocock D, Minthon L, Hansson O, Miles AK, Janciauskiene SM, Warden D, Smith AD, Wilcock G, Kalsheker N, Rees R, Matharoo-Ball B, Morgan K (2012) Identification of SPARClike 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid. J Alzheimers Dis 28, 625-636.
-
(2012)
J Alzheimers Dis
, vol.28
, pp. 625-636
-
-
Vafadar-Isfahani, B.1
Ball, G.2
Coveney, C.3
Lemetre, C.4
Boocock, D.5
Minthon, L.6
Hansson, O.7
Miles, A.K.8
Janciauskiene, S.M.9
Warden, D.10
Smith, A.D.11
Wilcock, G.12
Kalsheker, N.13
Rees, R.14
Matharoo-Ball, B.15
Morgan, K.16
-
83
-
-
79955781066
-
Identification of peripheral inflammatory markers between normal control and Alzheimer's disease
-
Kim SM, Song J, Kim S, Han C, Park MH,KohY, Jo SA, Kim YY (2011) Identification of peripheral inflammatory markers between normal control and Alzheimer's disease. BMC Neurol 11, 51.
-
(2011)
BMC Neurol
, vol.11
, pp. 51
-
-
Kim, S.M.1
Song, J.2
Kim, S.3
Han, C.4
Park, M.H.5
Koh, Y.6
Jo, S.A.7
Kim, Y.Y.8
-
84
-
-
33750455477
-
Subtype of mild cognitive impairment and progression to dementia and death
-
YaffeK, Petersen RC, Lindquist K, Kramer J, Miller B (2006) Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord 22, 312-319.
-
(2006)
Dement Geriatr Cogn Disord
, vol.22
, pp. 312-319
-
-
Yaffe, K.1
Petersen, R.C.2
Lindquist, K.3
Kramer, J.4
Miller, B.5
-
85
-
-
84867581107
-
The association between systemic inflammation and cognitive performance in the elderly: The Sydney Memory and Ageing Study
-
Trollor JN, Smith E, Agars E, Kuan SA, Baune BT, Campbell L, Samaras K, Crawford J, Lux O, Kochan NA, Brodaty H, Sachdev P (2012) The association between systemic inflammation and cognitive performance in the elderly: The Sydney Memory and Ageing Study. Age (Dordr) 34, 1295-1308.
-
(2012)
Age (Dordr)
, vol.34
, pp. 1295-1308
-
-
Trollor, J.N.1
Smith, E.2
Agars, E.3
Kuan, S.A.4
Baune, B.T.5
Campbell, L.6
Samaras, K.7
Crawford, J.8
Lux, O.9
Kochan, N.A.10
Brodaty, H.11
Sachdev, P.12
-
86
-
-
84897505354
-
Longitudinal change in CSF biomarkers in autosomaldominant Alzheimer's disease
-
Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, Marcus D, Cairns NJ, Buckles VD, Ladenson JH, Morris JC, HoltzmanDM,Dominantly Inherited AlzheimerN (2014) Longitudinal change in CSF biomarkers in autosomaldominant Alzheimer's disease. Sci Transl Med 6, 226ra230.
-
(2014)
Sci Transl Med
, vol.6
, pp. 226ra230
-
-
Dominantly Inherited AlzheimerN1
Fagan, A.M.2
Xiong, C.3
Jasielec, M.S.4
Bateman, R.J.5
Goate, A.M.6
Benzinger, T.L.7
Ghetti, B.8
Martins, R.N.9
Masters, C.L.10
Mayeux, R.11
Ringman, J.M.12
Rossor, M.N.13
Salloway, S.14
Schofield, P.R.15
Sperling, R.A.16
Marcus, D.17
Cairns, N.J.18
Buckles, V.D.19
Ladenson, J.H.20
Morris, J.C.21
Holtzman, D.M.22
more..
-
87
-
-
84867339786
-
Blood-based protein biomarkers for diagnosis of Alzheimer disease
-
Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, Macaulay SL, Pertile K, Rowe CC, Rembach A, Rodrigues M, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ames D, Masters CL, Martins RN (2012) Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol 69, 1318-1325.
-
(2012)
Arch Neurol
, vol.69
, pp. 1318-1325
-
-
Doecke, J.D.1
Laws, S.M.2
Faux, N.G.3
Wilson, W.4
Burnham, S.C.5
Lam, C.P.6
Mondal, A.7
Bedo, J.8
Bush, A.I.9
Brown, B.10
De Ruyck, K.11
Ellis, K.A.12
Fowler, C.13
Gupta, V.B.14
Head, R.15
Macaulay, S.L.16
Pertile, K.17
Rowe, C.C.18
Rembach, A.19
Rodrigues, M.20
Rumble, R.21
Szoeke, C.22
Taddei, K.23
Taddei, T.24
Trounson, B.25
Ames, D.26
Masters, C.L.27
Martins, R.N.28
more..
-
88
-
-
84897108729
-
A blood-based predictor for neocortical Abeta burden in Alzheimer's disease: Results from the AIBL study
-
Burnham SC, Faux NG,WilsonW, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, Salvado O, Macaulay SL, Masters CL, Villemagne VL, Alzheimer's Disease Neuroimaging I, Australian Imaging B, Lifestyle Study Research G (2014) A blood-based predictor for neocortical Abeta burden in Alzheimer's disease: Results from the AIBL study. Mol Psychiatry 19, 519-526.
-
(2014)
Mol Psychiatry
, vol.19
, pp. 519-526
-
-
Alzheimer's Disease Neuroimaging I, Australian Imaging B, Lifestyle Study Research G,1
Burnham, S.C.2
Faux, N.G.3
Wilson, W.4
Laws, S.M.5
Ames, D.6
Bedo, J.7
Bush, A.I.8
Doecke, J.D.9
Ellis, K.A.10
Head, R.11
Jones, G.12
Kiiveri, H.13
Martins, R.N.14
Rembach, A.15
Rowe, C.C.16
Salvado, O.17
Macaulay, S.L.18
Masters, C.L.19
Villemagne, V.L.20
more..
-
89
-
-
79953193799
-
Plasma apolipoprotein e and Alzheimer disease risk: The AIBL study of aging
-
Gupta VB, Laws SM, Villemagne VL, Ames D, Bush AI, Ellis KA, Lui JK, Masters C, Rowe CC, Szoeke C, Taddei K, Martins RN, Group AR (2011) Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging. Neurology 76, 1091-1098.
-
(2011)
Neurology
, vol.76
, pp. 1091-1098
-
-
Gupta, V.B.1
Laws, S.M.2
Villemagne, V.L.3
Ames, D.4
Bush, A.I.5
Ellis, K.A.6
Lui, J.K.7
Masters, C.8
Rowe, C.C.9
Szoeke, C.10
Taddei, K.11
Martins, R.N.12
-
90
-
-
84866973317
-
Proteins with altered levels in plasma from glioblastoma patients as revealed by iTRAQ-based quantitative proteomic analysis
-
Gautam P, Nair SC, Gupta MK, Sharma R, Polisetty RV, Uppin MS, Sundaram C, Puligopu AK, Ankathi P, Purohit AK, Chandak GR, Harsha HC, Sirdeshmukh R (2012) Proteins with altered levels in plasma from glioblastoma patients as revealed by iTRAQ-based quantitative proteomic analysis. PLoS One 7, e46153.
-
(2012)
PLoS One
, vol.7
-
-
Gautam, P.1
Nair, S.C.2
Gupta, M.K.3
Sharma, R.4
Polisetty, R.V.5
Uppin, M.S.6
Sundaram, C.7
Puligopu, A.K.8
Ankathi, P.9
Purohit, A.K.10
Chandak, G.R.11
Harsha, H.C.12
Sirdeshmukh, R.13
-
91
-
-
80053421975
-
Reduced serum vitamin Dbinding protein levels are associated with type 1 diabetes
-
Blanton D, Han Z, Bierschenk L, Linga-Reddy MV, Wang H, Clare-Salzler M, Haller M, Schatz D, Myhr C, She JX, Wasserfall C, Atkinson M (2011) Reduced serum vitamin Dbinding protein levels are associated with type 1 diabetes. Diabetes 60, 2566-2570.
-
(2011)
Diabetes
, vol.60
, pp. 2566-2570
-
-
Blanton, D.1
Han, Z.2
Bierschenk, L.3
Linga-Reddy, M.V.4
Wang, H.5
Clare-Salzler, M.6
Haller, M.7
Schatz, D.8
Myhr, C.9
She, J.X.10
Wasserfall, C.11
Atkinson, M.12
-
92
-
-
41649090385
-
'Deep phenotyping': Characterizing populations in the era of genomics and systems biology
-
Tracy RP (2008) 'Deep phenotyping': Characterizing populations in the era of genomics and systems biology. Curr Opin Lipidol 19, 151-157.
-
(2008)
Curr Opin Lipidol
, vol.19
, pp. 151-157
-
-
Tracy, R.P.1
-
93
-
-
84891112523
-
The future of blood-based biomarkers for Alzheimer's disease
-
Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, Lonneborg A, Wyss-Coray T, Soares H, Bazenet C, Sjogren M, Hu W, Lovestone S, Karsdal MA,WeinerMW, Blood-Based Biomarker InterestG (2014) The future of blood-based biomarkers for Alzheimer's disease. Alzheimers Dement 10, 115-131.
-
(2014)
Alzheimers Dement
, vol.10
, pp. 115-131
-
-
Blood-Based Biomarker InterestG1
Henriksen, K.2
O'bryant, S.E.3
Hampel, H.4
Trojanowski, J.Q.5
Montine, T.J.6
Jeromin, A.7
Blennow, K.8
Lonneborg, A.9
Wyss-Coray, T.10
Soares, H.11
Bazenet, C.12
Sjogren, M.13
Hu, W.14
Lovestone, S.15
Karsdal, M.A.16
Weiner, M.W.17
|